# SoFi Technologies, Inc.: financial statements, quarterly

SOFI · Nasdaq · CIK 1818874 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sofi.md) · [Financials](/companies/sofi/financials.md) · [Filings](/companies/sofi/filings.md) · [Insiders](/companies/sofi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/sofi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [105](/filings/0001818874-24-000233.md) | [116 d](/filings/0001818874-26-000013.md) | [116](/filings/0001818874-25-000072.md) | [121](/filings/0001818874-25-000180.md) | [131](/filings/0001818874-25-000210.md) | [136 d](/filings/0001818874-26-000013.md) | [140](/filings/0001818874-26-000037.md) | [152](/filings/0001818874-26-000054.md) | [157](/filings/0001818874-25-000210.md) | [170 d](/filings/0001818874-26-000013.md) | [130](/filings/0001818874-26-000037.md) | [154](/filings/0001818874-26-000054.md) |
| Cost of revenue | $m | [98.3](/filings/0001818874-24-000233.md) | [104 d](/filings/0001818874-26-000013.md) | [100](/filings/0001818874-25-000072.md) | [110](/filings/0001818874-25-000180.md) | [124](/filings/0001818874-25-000210.md) | [128 d](/filings/0001818874-26-000013.md) | [136](/filings/0001818874-26-000037.md) | [150](/filings/0001818874-26-000054.md) | [161](/filings/0001818874-25-000210.md) | [162 d](/filings/0001818874-26-000013.md) | [171](/filings/0001818874-26-000037.md) | [200](/filings/0001818874-26-000054.md) |
| Research and development | $m | [126](/filings/0001818874-24-000233.md) | [142 d](/filings/0001818874-26-000013.md) | [131](/filings/0001818874-25-000072.md) | [132](/filings/0001818874-25-000180.md) | [140](/filings/0001818874-25-000210.md) | [149 d](/filings/0001818874-26-000013.md) | [156](/filings/0001818874-26-000037.md) | [152](/filings/0001818874-26-000054.md) | [167](/filings/0001818874-25-000210.md) | [173 d](/filings/0001818874-26-000013.md) | [188](/filings/0001818874-26-000037.md) | [191](/filings/0001818874-26-000054.md) |
| Operating income | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Interest expense | $m | [219](/filings/0001818874-23-000173.md) | [256 d](/filings/0001818874-24-000026.md) | [263](/filings/0001818874-24-000121.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [(0.2)](/filings/0001818874-24-000233.md) | [3.2 d](/filings/0001818874-26-000013.md) | [6.2](/filings/0001818874-25-000072.md) | [(2.1)](/filings/0001818874-25-000180.md) | [3.1](/filings/0001818874-25-000210.md) | [(273) d](/filings/0001818874-26-000013.md) | [8.7](/filings/0001818874-26-000037.md) | [14.9](/filings/0001818874-26-000054.md) | [9.2](/filings/0001818874-25-000210.md) | [11.8 d](/filings/0001818874-26-000013.md) | [32.8](/filings/0001818874-26-000037.md) | [47.7](/filings/0001818874-26-000054.md) |
| Net income | $m | [(267)](/filings/0001818874-24-000233.md) | [47.9 d](/filings/0001818874-26-000013.md) | [88.0](/filings/0001818874-25-000072.md) | [17.4](/filings/0001818874-25-000180.md) | [60.7](/filings/0001818874-25-000210.md) | [332 d](/filings/0001818874-26-000013.md) | [71.1](/filings/0001818874-26-000037.md) | [97.3](/filings/0001818874-26-000054.md) | [139](/filings/0001818874-25-000210.md) | [174 d](/filings/0001818874-26-000013.md) | [167](/filings/0001818874-26-000037.md) | [157](/filings/0001818874-26-000054.md) |
| Diluted EPS | $ per share | [(0.29)](/filings/0001818874-24-000233.md) | not reported | [0.02](/filings/0001818874-25-000072.md) | [0.01](/filings/0001818874-25-000180.md) | [0.05](/filings/0001818874-25-000210.md) | not reported | [0.06](/filings/0001818874-26-000037.md) | [0.08](/filings/0001818874-26-000054.md) | [0.11](/filings/0001818874-25-000210.md) | not reported | [0.12](/filings/0001818874-26-000037.md) | [0.12](/filings/0001818874-26-000054.md) |
| Basic EPS | $ per share | [(0.29)](/filings/0001818874-24-000233.md) | not reported | [0.08](/filings/0001818874-25-000072.md) | [0.01](/filings/0001818874-25-000180.md) | [0.06](/filings/0001818874-25-000210.md) | not reported | [0.06](/filings/0001818874-26-000037.md) | [0.09](/filings/0001818874-26-000054.md) | [0.12](/filings/0001818874-25-000210.md) | not reported | [0.13](/filings/0001818874-26-000037.md) | [0.12](/filings/0001818874-26-000054.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfRevenue
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Operating income: not reported
- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $bn | [2.8](/filings/0001818874-24-000233.md) | [3.1](/filings/0001818874-26-000013.md) | [3.7](/filings/0001818874-25-000072.md) | [2.3](/filings/0001818874-25-000180.md) | [2.4](/filings/0001818874-25-000210.md) | [2.5](/filings/0001818874-26-000013.md) | [2.1](/filings/0001818874-26-000037.md) | [2.1](/filings/0001818874-26-000054.md) | [3.2](/filings/0001818874-25-000210.md) | [4.9](/filings/0001818874-26-000054.md) | [3.4](/filings/0001818874-26-000037.md) | [3.1](/filings/0001818874-26-000054.md) |
| Current assets | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total assets | $bn | [28.0](/filings/0001818874-23-000173.md) | [30.1](/filings/0001818874-25-000016.md) | [31.3](/filings/0001818874-24-000121.md) | [32.6](/filings/0001818874-24-000175.md) | [34.4](/filings/0001818874-24-000233.md) | [36.3](/filings/0001818874-26-000013.md) | [37.7](/filings/0001818874-25-000072.md) | [41.1](/filings/0001818874-25-000180.md) | [45.3](/filings/0001818874-25-000210.md) | [50.7](/filings/0001818874-26-000054.md) | [53.7](/filings/0001818874-26-000037.md) | [60.9](/filings/0001818874-26-000054.md) |
| Current liabilities | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Total liabilities | $bn | [22.6](/filings/0001818874-23-000173.md) | [24.5](/filings/0001818874-25-000016.md) | [25.2](/filings/0001818874-24-000121.md) | [26.7](/filings/0001818874-24-000175.md) | [28.3](/filings/0001818874-24-000233.md) | [29.7](/filings/0001818874-26-000013.md) | [31.1](/filings/0001818874-25-000072.md) | [34.3](/filings/0001818874-25-000180.md) | [36.5](/filings/0001818874-25-000210.md) | [40.2](/filings/0001818874-26-000054.md) | [42.9](/filings/0001818874-26-000037.md) | [49.9](/filings/0001818874-26-000054.md) |
| Long-term debt | $bn | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $bn | [5.1](/filings/0001818874-24-000233.md) | [5.2](/filings/0001818874-26-000013.md) | [5.8](/filings/0001818874-25-000180.md) | [5.9](/filings/0001818874-25-000210.md) | [6.1](/filings/0001818874-25-000210.md) | [6.5](/filings/0001818874-26-000054.md) | [6.7](/filings/0001818874-26-000054.md) | [6.9](/filings/0001818874-26-000054.md) | [8.8](/filings/0001818874-25-000210.md) | [10.5](/filings/0001818874-26-000054.md) | [10.8](/filings/0001818874-26-000054.md) | [11.1](/filings/0001818874-26-000054.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: not reported
- Total assets: us-gaap:Assets
- Current liabilities: not reported
- Total liabilities: us-gaap:Liabilities
- Long-term debt: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [(2,687) d](/filings/0001818874-24-000233.md) | [(248) d](/filings/0001818874-26-000013.md) | [738](/filings/0001818874-25-000072.md) | [(484) d](/filings/0001818874-25-000180.md) | [(1,174) d](/filings/0001818874-25-000210.md) | [(200) d](/filings/0001818874-26-000013.md) | [21.5](/filings/0001818874-26-000037.md) | [(1,467) d](/filings/0001818874-26-000054.md) | [(1,306) d](/filings/0001818874-25-000210.md) | [(991) d](/filings/0001818874-26-000013.md) | [(2,315)](/filings/0001818874-26-000037.md) | [(3,890) d](/filings/0001818874-26-000054.md) |
| Capital expenditure | $m | [28.0 d](/filings/0001818874-24-000233.md) | [34.3 d](/filings/0001818874-26-000013.md) | [32.0](/filings/0001818874-25-000072.md) | [36.7 d](/filings/0001818874-25-000180.md) | [43.3 d](/filings/0001818874-25-000210.md) | [42.3 d](/filings/0001818874-26-000013.md) | [52.6](/filings/0001818874-26-000037.md) | [63.5 d](/filings/0001818874-26-000054.md) | [60.0 d](/filings/0001818874-25-000210.md) | [66.4 d](/filings/0001818874-26-000013.md) | [67.6](/filings/0001818874-26-000037.md) | [96.6 d](/filings/0001818874-26-000054.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquireProductiveAssets
- Share repurchases: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [917](/filings/0001818874-23-000173.md) | [929](/filings/0001818874-24-000121.md) | [937](/filings/0001818874-24-000175.md) | [951](/filings/0001818874-24-000233.md) | [1,042](/filings/0001818874-25-000072.md) | [1,065](/filings/0001818874-25-000180.md) | [1,104](/filings/0001818874-25-000210.md) | [1,185](/filings/0001818874-26-000037.md) | [1,183](/filings/0001818874-26-000054.md) | [1,291](/filings/0001818874-25-000210.md) | [1,378](/filings/0001818874-26-000037.md) | [1,352](/filings/0001818874-26-000054.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 1,291,570,324 at 2026-07-31, from the cover of the [10-Q filed 2026-08-06](/filings/0001818874-26-000054.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:48 ET. No prices; not investment advice.